Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

471
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
471
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.6K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning phenotypes and heterogeneous albumin effects in cirrhotic AKI: a causal inference study.

Internal and emergency medicine·2026
Same author

GALNT5 drives colorectal cancer progression and chemoresistance via PI3K/Akt/ABCC1 axis.

Journal of cancer research and clinical oncology·2026
Same author

Effects of rumen fluid transplantation on longissimus dorsi muscle development in Xizang sheep: An association analysis based on transcriptomic and serum metabolomic profiles.

Comparative biochemistry and physiology. Part D, Genomics & proteomics·2026
Same author

From one to twelve: feasibility and clinical utility of deep learning-derived 12-lead ECGs for remote cardiac monitoring.

Frontiers in cardiovascular medicine·2026
Same author

Tai Chi, brain activity and psychological outcomes: a systematic scoping review.

Frontiers in psychology·2026
Same author

Multi-omics reveals goat milk improves glucose homeostasis in type 2 diabetes mellitus mice by gut-liver axis.

Food chemistry: X·2026
Same journal

HER2-mutated lung squamous cell carcinoma responding to trastuzumab deruxtecan followed by pyrotinib: a Case Report.

Frontiers in pharmacology·2026
Same journal

Awareness, attitudes, and self-reported clinical management of antimicrobial-associated neurocognitive adverse effects among healthcare providers in Saudi Arabia.

Frontiers in pharmacology·2026
Same journal

Low-dose dasatinib in second-line therapy or beyond for the treatment of chronic-phase chronic myeloid leukemia: a real-world cohort study.

Frontiers in pharmacology·2026
Same journal

Natural products reshape osteosarcoma cell fate: promoting cell death.

Frontiers in pharmacology·2026
Same journal

<i>Leonurus japonicus</i> Houtt. extract containing isoquercitrin reduces airway inflammation in mice with allergic asthma.

Frontiers in pharmacology·2026
Same journal

Enhancing diabetes treatment by targeted nucleic acid and drug delivery using cell-penetrating peptides, peptide nucleic acids, and receptor targeting.

Frontiers in pharmacology·2026
See all related articles

Related Experiment Video

Updated: May 21, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Efficient substructure feature encoding based on graph neural network blocks for drug-target interaction prediction.

Guojian Deng1, Changsheng Shi2, Ruiquan Ge1,3

  • 1School of Computer Science, Hangzhou Dianzi University, Hangzhou, China.

Frontiers in Pharmacology
|March 20, 2025
PubMed
Summary
This summary is machine-generated.

GNNBlockDTI improves drug-target interaction prediction by effectively learning drug molecular graph features. This novel approach balances local and global structural information for enhanced drug discovery.

Keywords:
drug discoverydrug-target interaction predictiongraph neural networkgraph representation learningmolecular substructure

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Related Experiment Videos

Last Updated: May 21, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Drug discovery

Background:

  • Drug-target interaction (DTI) prediction is vital for drug discovery.
  • Graph neural networks (GNNs) show promise for drug feature encoding.
  • Existing GNN methods struggle to balance local and global drug molecular graph features.

Purpose of the Study:

  • To develop a novel model, GNNBlockDTI, for improved DTI prediction.
  • To enhance the representation learning of drug molecules and target proteins.
  • To address limitations in current GNN-based DTI prediction methods.

Main Methods:

  • Proposed GNNBlockDTI model incorporating GNNBlocks for local pattern capture.
  • Implemented a feature enhancement strategy with gating units for refined drug features.
  • Utilized variant convolutional networks for local encoding of target protein binding sites.

Main Results:

  • GNNBlockDTI demonstrated competitive performance against state-of-the-art models on benchmark datasets.
  • Experimental results confirmed the model's high efficacy in DTI prediction.
  • A case study validated the practical utility of GNNBlockDTI for drug candidate ranking.

Conclusions:

  • GNNBlockDTI offers a robust framework for DTI prediction.
  • The model effectively integrates local and global structural information for better predictions.
  • GNNBlockDTI shows significant potential for accelerating drug discovery pipelines.